Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Paula Riggs to Substance-Related Disorders

This is a "connection" page, showing publications Paula Riggs has written about Substance-Related Disorders.

 
Connection Strength
  
 
 
4.885
  
  1. Riggs P. A Pragmatic Clinical Approach to Substance Abuse Prevention. Psychiatr Clin North Am. 2023 12; 46(4):741-748.
    View in: PubMed
    Score: 0.501
  2. Hinckley JD, Riggs P. Integrated Treatment of Adolescents with Co-occurring Depression and Substance Use Disorder. Child Adolesc Psychiatr Clin N Am. 2019 07; 28(3):461-472.
    View in: PubMed
    Score: 0.363
  3. Hsiao RC, Riggs PD. The Changing Landscape of Adolescent Substance Treatment. Child Adolesc Psychiatr Clin N Am. 2016 Oct; 25(4):xv-xvi.
    View in: PubMed
    Score: 0.305
  4. Robinson ZD, Riggs PD. Cooccurring Psychiatric and Substance Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Oct; 25(4):713-22.
    View in: PubMed
    Score: 0.302
  5. LeNoue SR, Riggs PD. Substance Abuse Prevention. Child Adolesc Psychiatr Clin N Am. 2016 Apr; 25(2):297-305.
    View in: PubMed
    Score: 0.290
  6. Riggs PD. Stimulant medication for ADHD not associated with subsequent substance use disorders. Evid Based Med. 2014 Apr; 19(2):78.
    View in: PubMed
    Score: 0.250
  7. Tamm L, Adinoff B, Nakonezny PA, Winhusen T, Riggs P. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse. 2012 Jan; 38(1):93-100.
    View in: PubMed
    Score: 0.213
  8. Riggs PD, Winhusen T, Davies RD, Leimberger JD, Mikulich-Gilbertson S, Klein C, Macdonald M, Lohman M, Bailey GL, Haynes L, Jaffee WB, Haminton N, Hodgkins C, Whitmore E, Trello-Rishel K, Tamm L, Acosta MC, Royer-Malvestuto C, Subramaniam G, Fishman M, Holmes BW, Kaye ME, Vargo MA, Woody GE, Nunes EV, Liu D. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2011 Sep; 50(9):903-14.
    View in: PubMed
    Score: 0.213
  9. Thurstone C, Salomensen-Sautel S, Riggs PD. How adolescents with substance use disorder spend research payments. Drug Alcohol Depend. 2010 Oct 01; 111(3):262-4.
    View in: PubMed
    Score: 0.197
  10. Riggs P. Non-medical use and abuse of commonly prescribed medications. Curr Med Res Opin. 2008 Mar; 24(3):869-77.
    View in: PubMed
    Score: 0.167
  11. Riggs P, Levin F, Green AI, Vocci F. Comorbid psychiatric and substance abuse disorders: recent treatment research. Subst Abus. 2008; 29(3):51-63.
    View in: PubMed
    Score: 0.166
  12. Riggs PD, Thompson LL, Tapert SF, Frascella J, Mikulich-Gilbertson S, Dalwani M, Laudenslager M, Lohman M. Advances in neurobiological research related to interventions in adolescents with substance use disorders: research to practice. Drug Alcohol Depend. 2007 Dec 01; 91(2-3):306-11.
    View in: PubMed
    Score: 0.165
  13. Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007 Nov; 161(11):1026-34.
    View in: PubMed
    Score: 0.164
  14. Libby AM, Riggs PD. Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):826-34.
    View in: PubMed
    Score: 0.142
  15. Libby AM, Orton HD, Stover SK, Riggs PD. What came first, major depression or substance use disorder? Clinical characteristics and substance use comparing teens in a treatment cohort. Addict Behav. 2005 Oct; 30(9):1649-62.
    View in: PubMed
    Score: 0.141
  16. Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 2004 Apr; 43(4):420-9.
    View in: PubMed
    Score: 0.128
  17. Riggs PD. Treating adolescents for substance abuse and comorbid psychiatric disorders. Sci Pract Perspect. 2003 Aug; 2(1):18-29.
    View in: PubMed
    Score: 0.122
  18. Riggs PD, Leon SL, Mikulich SK, Pottle LC. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998 Dec; 37(12):1271-8.
    View in: PubMed
    Score: 0.089
  19. Riggs PD. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998 Mar; 37(3):331-2.
    View in: PubMed
    Score: 0.084
  20. Al-Tayyib A, Riggs P, Mikulich-Gilbertson S, Hopfer C. Prevalence of Nonmedical Use of Prescription Opioids and Association With Co-occurring Substance Use Disorders Among Adolescents in Substance Use Treatment. J Adolesc Health. 2018 02; 62(2):241-244.
    View in: PubMed
    Score: 0.082
  21. Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. Fluoxetine in drug-dependent delinquents with major depression: an open trial. J Child Adolesc Psychopharmacol. 1997; 7(2):87-95.
    View in: PubMed
    Score: 0.078
  22. Wagner B, Riggs P, Mikulich-Gilbertson S. The importance of distribution-choice in modeling substance use data: a comparison of negative binomial, beta binomial, and zero-inflated distributions. Am J Drug Alcohol Abuse. 2015; 41(6):489-97.
    View in: PubMed
    Score: 0.070
  23. Riggs PD, Baker S, Mikulich SK, Young SE, Crowley TJ. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry. 1995 Jun; 34(6):764-71.
    View in: PubMed
    Score: 0.069
  24. Benningfield MM, Riggs P, Stephan SH. The role of schools in substance use prevention and intervention. Child Adolesc Psychiatr Clin N Am. 2015 Apr; 24(2):291-303.
    View in: PubMed
    Score: 0.069
  25. Crowley TJ, Riggs PD. Adolescent substance use disorder with conduct disorder and comorbid conditions. NIDA Res Monogr. 1995; 156:49-111.
    View in: PubMed
    Score: 0.067
  26. Tamm L, Trello-Rishel K, Riggs P, Nakonezny PA, Acosta M, Bailey G, Winhusen T. Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. J Subst Abuse Treat. 2013 Feb; 44(2):224-30.
    View in: PubMed
    Score: 0.057
  27. Winhusen TM, Lewis DF, Riggs PD, Davies RD, Adler LA, Sonne S, Somoza EC. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):455-63.
    View in: PubMed
    Score: 0.054
  28. Warden D, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Tamm L, Trello-Rishel K, Winhusen T. Major depression and treatment response in adolescents with ADHD and substance use disorder. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):214-9.
    View in: PubMed
    Score: 0.054
  29. Gray KM, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Bandyopadhyay D, Winhusen T. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7.
    View in: PubMed
    Score: 0.052
  30. Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry. 2010 Jun; 49(6):573-82.
    View in: PubMed
    Score: 0.049
  31. Jaffee WB, Bailey GL, Lohman M, Riggs P, McDonald L, Weiss RD. Methods of recruiting adolescents with psychiatric and substance use disorders for a clinical trial. Am J Drug Alcohol Abuse. 2009; 35(5):381-4.
    View in: PubMed
    Score: 0.045
  32. Thurstone C, Riggs PD, Klein C, Mikulich-Gilbertson SK. A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. J Am Acad Child Adolesc Psychiatry. 2007 Sep; 46(9):1179-1186.
    View in: PubMed
    Score: 0.041
  33. Helstrom A, Bryan A, Hutchison KE, Riggs PD, Blechman EA. Tobacco and alcohol use as an explanation for the association between externalizing behavior and illicit drug use among delinquent adolescents. Prev Sci. 2004 Dec; 5(4):267-77.
    View in: PubMed
    Score: 0.034
  34. Deas D, Riggs P, Langenbucher J, Goldman M, Brown S. Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin Exp Res. 2000 Feb; 24(2):232-7.
    View in: PubMed
    Score: 0.024
  35. Whitmore EA, Mikulich SK, Thompson LL, Riggs PD, Aarons GA, Crowley TJ. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend. 1997 Aug 25; 47(2):87-97.
    View in: PubMed
    Score: 0.020
  36. Thompson LL, Riggs PD, Mikulich SK, Crowley TJ. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. J Abnorm Child Psychol. 1996 Jun; 24(3):325-47.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)